New Study Finds That Avocados May Help Combat Blood Cancer

The health benefits of avocados are no secret, and have of the past few years become the go-to topping for chips and crackers, and even the go-to condiments for sandwiches. Avocados have already been proven to help fight a few serious diseases, like diabetes and health-related disorders. The inner portion of avocados reportedly falls under the “good fats’ category and, therefore, gives off antioxidants, which makes for healthy skin. Avocados are also known to help reduce bad cholesterol. A new study now reveals that avocados may also be essential in curing blood cancer.

From avocados, scientists have created a avocado-based compound known as Avocatin B. This compound has been used so far to treat Acute Myleoid Leukemia (AML), more commonly called blood cancer. The study, which appears in the oncology journal Cancer Research, is the result of a partnership with the Centre for Commercialisation of Regenerative Medicine, according to the Empire State Tribune. The study revealed some beneficial properties in avocados that were unknown before.

The research, conducted at University of Waterloo in Canada, found that scientists could treat blood cancer with avocados by targeting the root of diseased leukemia stem cells. Researcher Paul Spagnuolo at University of Waterloo explained the research with led him to the conclusion that stem cells can treat AML.

“The stem cells are largely responsible for AML and it is the reason why so many patients with leukemia relapse. We have performed many rounds of testing to determine how this new drug works at a molecular level and confirmed that it targets stem cells selectively, leaving healthy cells unharmed.”

The study found that the compound Avocatin B made from avocados, kills the source cells of AML, aiding in the treatment of blood cancer. The same group of researchers plan to begin trials to test the avocado based compound for its ability to actually cure blood cancer.

“Not only does Avocatin B eliminate the source of blood cancer, but its targeted, selective effects make it less toxic to the body too. It is an exciting time for our lab. With the help of CCRM we are now pursuing commercial partnership that would take Avocatin B into clinical trials.”

The researchers at University of Waterloo have already signed up patients to test avocados as a treatment for their blood cancer. So far, the initial study has found that avocados, or more specifically the avocado-derived Avocatin B, does have the ability to increase life expectancy in patients with AML. The question remaining is, can avocados assist in curing blood cancer altogether? Researchers plan to begin their trials soon to find out.